Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients.
about
Undernutrition in patients with COPD and its treatmentNutritional supplementation for stable chronic obstructive pulmonary diseaseNutritional supplementation for stable chronic obstructive pulmonary diseaseSkeletal muscle dysfunction in chronic obstructive pulmonary diseaseTumor necrosis factor-alpha and muscle wasting: a cellular perspectiveInflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).Chronic obstructive pulmonary disease patients have greater systemic responsiveness to ex vivo stimulation with swine dust extract and its components versus healthy volunteersPredictors of mortality in elderly subjects with obstructive airway disease: the PILE scoreInflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.TNFA-863 polymorphism is associated with a reduced risk of chronic obstructive pulmonary disease: a replication study.Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease. 5: systemic effects of COPDUpdate on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease * 12: New treatments for COPDMuscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease.Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease.Leptin in anorexia and cachexia syndrome.Serum Vitamin A and Inflammatory Markers in Individuals with and without Chronic Obstructive Pulmonary Disease.Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsPhysical activity and modulation of systemic low-level inflammation.Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha release.Nutritional management of the patient with chronic obstructive pulmonary disease.Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients.Genetics and the Dutch Hypothesis.Malnutrition and ageing.Infliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting?Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities.Increased production of hydrogen peroxide by peripheral blood monocytes associated with smoking exposure intensity in smokers.Mechanisms of physical activity limitation in chronic lung diseases.Systemic inflammation in COPD: is genetic susceptibility a key factor?Systemic manifestations in chronic obstructive pulmonary disease.Aspects on pathophysiological mechanisms in COPD.Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease.COPD as a systemic disease.Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease.The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.Plasma inflammatory biomarkers response to aerobic versus resisted exercise training for chronic obstructive pulmonary disease patients.Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease.
P2860
Q22305600-86D23C0D-34FD-4916-A44E-F65638A6F30FQ24202330-C9ACD8A8-7BD0-468D-9BEC-55D2AF63A6C1Q24244188-305B2944-572B-4DB0-8561-8C27C8FFE732Q24792076-59E796F8-9DFF-4D77-AFED-11DC45AE555AQ24806646-F13D4970-9B12-45E3-9D93-10C9C3511F5BQ26830867-E16B1166-00D7-4FF1-9471-2534D6FD9F53Q28384754-3F661388-4841-4E5F-815F-60AF59D5B06DQ33683010-D7A3CF2B-AFEB-4FDB-BE5A-5764BD8B0DFDQ33880491-DD7BAA99-0BCD-4ABA-8021-E253D7159002Q34045375-E70FDA6E-A395-4987-9316-BC7CF93C86DDQ34442689-F38E8C2E-BDF0-4BAB-9DF2-7980F3D90D41Q35009945-CABAEF3B-1392-4B4B-AAC7-35954502D897Q35028812-9CA4712F-3DD5-42AB-8A11-59AB58BD6276Q35208742-353ABB1F-C315-4DC9-AA05-2D0152EFFFA2Q35536202-BEBA607A-76EC-40DD-89E9-CB7C1ACBB1D7Q35536791-803F5A99-1A12-48A5-BD12-837DB0B23EE4Q35690112-49298ED4-B8CF-4A7F-8B37-81E16B3D0151Q35779864-37C5F80C-BD7F-44B6-912C-F4B4A77A5FC8Q35829778-F7EEE9C5-6247-4A52-A07D-EC5E6AD1EA64Q35963109-B65A642B-59CB-4189-A3CF-AC8AFA7D153FQ36148605-90E6E756-5F56-4AF2-B38D-8E47AFBB088CQ36201980-BCC2DB8B-EC2D-4BB6-BB55-CCAFB7EE120BQ36203159-EC52AD88-0617-4C30-A971-FDB97A1CCD45Q36281779-4EF99682-473C-4D5C-8542-CDEE4CB4DD49Q36293943-B51A0AF9-6A95-49B1-A692-5F7F2DB06268Q36309975-B0E4281D-DDE8-4273-9379-DE410C776A25Q36362185-341C3F96-4A29-4CF3-B6A2-A942829EA00BQ36376453-7ADDF414-E639-4C00-A90C-F830C776BA5DQ36443665-397D2689-718D-4507-8D2B-41CAECA43231Q36478484-F28DA0C7-56CF-4134-9AF8-8C5655FA03B7Q36490588-2B743C53-3266-4335-8D70-64664302D7AFQ36686862-A45AE4A6-B1D5-40E1-AAAA-0307D935E751Q36726350-8F1B0467-D814-49AF-910C-EBA5345FA55FQ36909567-CB7D853B-F61F-4661-B719-2F06F17E82E4Q37016623-5F923BD7-95EF-482B-AF73-A5E29BCA853CQ37139528-D6D85A8A-A73D-4BC9-8A48-662662DAC599Q37162926-232E02B3-2EB5-4957-8E04-7D496BA227ADQ37168309-16DEEB74-BC3B-4E81-922E-BB01F243FD0EQ37196808-93AA9EFD-CAB9-4BA2-81FE-B901C02E2E01Q37413293-4C614F23-F38F-40BA-A389-6A52DDF81560
P2860
Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Elevated TNF-alpha production ...... f weight-losing COPD patients.
@en
Elevated TNF-alpha production ...... f weight-losing COPD patients.
@nl
type
label
Elevated TNF-alpha production ...... f weight-losing COPD patients.
@en
Elevated TNF-alpha production ...... f weight-losing COPD patients.
@nl
prefLabel
Elevated TNF-alpha production ...... f weight-losing COPD patients.
@en
Elevated TNF-alpha production ...... f weight-losing COPD patients.
@nl
P2093
P1476
Elevated TNF-alpha production ...... f weight-losing COPD patients.
@en
P2093
P304
P356
10.1164/AJRCCM.153.2.8564110
P407
P577
1996-02-01T00:00:00Z